Description
Presented at ARA Annual Scientific Meeting May 2021
Aims to describe prescribing patterns for biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for rheumatoid arthritis in Australia.
Presented at ARA Annual Scientific Meeting May 2021
Aims to describe prescribing patterns for biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for rheumatoid arthritis in Australia.